Testing effectiveness (Phase 2)Ended earlyNCT06435845
What this trial is testing
Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization
Who this might be right for
Fetal and Neonatal Alloimmune Thrombocytopenia
Rallybio 1